Impact of Iron Supplementation on Haemoglobin Levels and Quality-of-life in Iron-deficient (Anaemic) Women Before and After Delivery
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 800
- 试验地点
- 2
- 主要终点
- Proportion of patients achieving an increase in hemoglobin concentration of ≥1 g/dL
研究概览
简要总结
During pregnancy, iron deficiency is the most common cause of anemia. Anemia is very common during pregnancy and after childbirth. Around half of pregnant women develop anemia, and after delivery, up to 85% of women may be affected.
This study looks at whether iron given through a vein (intravenous iron) can improve blood levels and how women feel and function in everyday life before and after giving birth.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Pregnancy
排除标准
- •Thalassemia
- •Sickle cell disease
- •Aplastic anemia
- •Hemochromatosis
- •Chronic inflammatory diseases associated with anemia of chronic disease
- •Severe renal insufficiency
- •Intravenous iron administration within 3 months prior to enrollment
结局指标
主要结局
Proportion of patients achieving an increase in hemoglobin concentration of ≥1 g/dL
时间窗: between iron supplementation and follow-up: 2-4 weeks
Proportion of patients with an increase in hemoglobin concentration of ≥1 g/dL from before the first intravenous iron administration to the last available measurement before delivery
次要结局
未报告次要终点
研究者
Dr. Patrick Meybohm, M.D.
Professor
Johann Wolfgang Goethe University Hospital